Omega Therapeutics, Inc. 8-K Report: Major Updates for Investors

Based on the provided XML section of a financial report, here are the key pieces of information extracted:

Filing Type: The document is an 8-K, which is a report that companies must file with the SEC to announce major events that shareholders should know about.
Company Information:

Name: Omega Therapeutics, Inc.
CIK (Central Index Key): 0001850838
State of Incorporation: Delaware (DE)
SEC File Number: 001-40657
EIN (Employer Identification Number): 81-3247585
Headquarters Address: 140 First Street, Suite 501, Cambridge, MA 02141
Contact Number: (617) 949-4360

Stock Information:

Common Stock Par Value: $0.001 per share
Ticker Symbol: OMGA
Stock Exchange: NASDAQ

Reporting Period:

Report Date: January 13, 2025
Period of the Report: The context indicates a single-day reporting period (January 13, 2025).

This report provides essential details about the company, including its identification, stock details, and the nature of the filing. The 8-K filing suggests that there may be significant news or events that warrant immediate disclosure to investors.